Pasithea Therapeutics Corp share price logo

Pasithea Therapeutics Corp

NASDAQ: KTTA

$0.46

-0.02

(-4.15%)

Live

as on

Pasithea Therapeutics Corp Stock Performance

as on September 30, 2026 at 1:02 am IST

  • Day's Low

    Day's High

    $0.46
    $0.47
    downward going graph

    0.02%

    Downside

    2.15%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.28
    $2.06
    downward going graph

    38.93%

    Downside

    347.73%

    Upside

    downward going graph

Pasithea Therapeutics Corp share price movements today

Previous Close
$0.48
Open
$0.47
Volume
2.3K
Market Cap
$16.7M
Day's Low - High
$0.46 - $0.47
52 Week Low - High
$0.28 - $2.06

Pasithea Therapeutics Corp Historical Returns

1 Month Return
-14.29 %
3 Month Return
-8.76 %
1 Year Return
-33.33 %
3 Year Return
-95 %
5 Year Return
-99.16 %

Pasithea Therapeutics Corp Stock Fundamentals & Key Indicators

Check Pasithea Therapeutics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$16.7M

EPS (TTM)

-2.46

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.2

Industry PE ratio

-2.66

PEG Ratio

-0.001467128899178971

EBITDA

-23.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-49.49%

Pasithea Therapeutics Corp Stock Valuation

Track how Pasithea Therapeutics Corp P/E has moved over time to understand its valuation trends.

Pasithea Therapeutics Corp in the last 5 years

  • Overview

  • Trends

Lowest (-18.74x)

December 31, 2021

Industry (-2.66x)

December 31, 2025

Today (-0.44x)

December 31, 2025

Highest (-0.25x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.44x

Pasithea Therapeutics Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pasithea Therapeutics Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$16.7M-99.16%-0.20.00%0.00%
StrongBuy$43.9B628.83%-23.130.00%0.00%
Neutral$79.4B-47.93%-24.92-12.57%0.00%
StrongBuy$133.4B189.75%30.3886.04%0.00%
Buy$81.1B23.99%18.8284.86%0.47%

Stock Returns calculator for Pasithea Therapeutics Corp Stock including INR - Dollar returns

The Pasithea Therapeutics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pasithea Therapeutics Corp investment value today

Current value as on today

₹69,144

Returns

-₹30,856

(-30.86%)

Returns from Pasithea Therapeutics Corp Stock

-₹36,097 (-36.1%)

Dollar Impact

₹5,242 (+5.24%)

Analyst Recommendation on Pasithea Therapeutics Corp Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Pasithea Therapeutics Corp. Average target price of $3

Pasithea Therapeutics Corp Share Price Target

Get share price movements and forecasts by analysts on Pasithea Therapeutics Corp.

What analysts predicted

84.66%UPSIDE

Target Price

$3

Current Price

$0.4601

Analyzed by

7 Analysts

Target

$3.00

Pasithea Therapeutics Corp target price $3, a slight upside of 84.66% compared to current price of $0.4601. According to 7 analysts rating.

Indian Investors' Interest in Pasithea Therapeutics Corp Stock

Search interest for Pasithea Therapeutics Corp Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-19% versus previous 30 day period

Pasithea Therapeutics Corp Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
0
-
-
-
0
0
0
Operating Income
-4
-3
-3
-3
-3
-3
-3
-10
-4
-5
EBITDA
-3
-3
-2
-3
-3
-3
-2
-10
-4
-5
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-3
-2
-3
-3
-3
-3
-10
-2
-5
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-3
-2
-3
-3
-3
-3
-10
-2
-5
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Pasithea Therapeutics Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
-
-
-
-
Gross Profit
-
0
0
-
-
-
Operating Income
0
-4
-12
-15
-14
-20
EBITDA
-
-2
-11
-15
-13
-20
Interest Expense
-
0
0
-
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
0
-2
-11
-15
-13
-20
Income Tax Expense
-
-
-
-
-
-
Net Income
0
-2
-13
-15
-13
-20
Net Profit Margin
0.00%
-14.69%
0.00%
0.00%
0.00%
0.00%

Pasithea Therapeutics Corp Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-3
-2
-3
-3
-3
-3
-10
-2
-8,140
Operating Cash Flow
-4
-4
-3
-2
-3
-3
-2
-5
-4
-4
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
-
4
0
1
5
0
56
0
0
Change in Cash
-4
-4
1
-2
-1
1
-2
51
-4
-4

Pasithea Therapeutics Corp Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-2
-11
-15
-13
-20
Operating Cash Flow
0
-3
-13
-13
-13
-15
Investing Cash Flow
-
0
-2
0
-
0
Financing Cash Flow
0
55
-3
-3
4
63
Change in Cash
0
52
-19
-16
-9
48

Mutual Funds that own Pasithea Therapeutics Corp Stock

Check out the Mutual Funds with significant holdings in Pasithea Therapeutics Corp.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
0.161053%
53815
Fidelity Concord Street Trust
0.148369%
49577

Global Institutional Holdings in Pasithea Therapeutics Corp

Funds
Holdings
AdvisorShares
3.47%
Vanguard
0.38%
VANGUARD INDEX FUNDS
0.16%
Fidelity Concord Street Trust
0.15%

Insights on Pasithea Therapeutics Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 678.8% return, outperforming this stock by 712.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 91.0% return, outperforming this stock by 186.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 976.30K → 649.02K (in $), with an average decrease of 33.5% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, KTTA stock has moved down by -95.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -2.86M → -5.27M (in $), with an average decrease of 83.8% per quarter

About Pasithea Therapeutics Corp

Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
OrganisationPasithea Therapeutics Corp
Headquarters1111 Lincoln Road, Miami Beach, FL, 33139, US
IndustryBiotechnology
CEOTiago Reis Marques
E-voting on sharesClick here to vote

Key Management of Pasithea Therapeutics Corp

Name

Title

Dr. Lawrence Steinman BA, M.D., Ph.D.

Co-Founder & Executive Chairman

Dr. Tiago Reis Marques M.D., Ph.D.

CEO & Director

Mr. Daniel H. Schneiderman

Chief Financial Officer

Dr. Kartik Krishnan M.D., Ph.D.

Chief Medical Officer

FAQs

What is Pasithea Therapeutics Corp share price today?

Pasithea Therapeutics Corp share price today is $0.46 as on . Pasithea Therapeutics Corp share today touched a day high of $0.47 and a low of $0.46.

What is the 52 week high and 52 week low for Pasithea Therapeutics Corp share?

Pasithea Therapeutics Corp share touched a 52 week high of $2.06 on and a 52 week low of $0.28 on . Pasithea Therapeutics Corp stock price today i.e. is trending at $0.46,which is 77.67% down from its 52 week high and 63.74% up from its 52 week low.

What is Pasithea Therapeutics Corp's market capitalisation today?

Pasithea Therapeutics Corp market capitalisation is $0.00T as on .

How to invest in Pasithea Therapeutics Corp Stock (KTTA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pasithea Therapeutics Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pasithea Therapeutics Corp Shares that will get you 3.2602 shares as per Pasithea Therapeutics Corp share price of $0.46 per share as on September 29, 2026 at 7:32 pm IST.

What is the minimum amount required to buy Pasithea Therapeutics Corp Stock (KTTA) from India?

Indian investors can start investing in Pasithea Therapeutics Corp (KTTA) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Pasithea Therapeutics Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Pasithea Therapeutics Corp share’s latest price of $0.46 as on September 29, 2026 at 7:32 pm IST, you will get 21.7344 shares of Pasithea Therapeutics Corp. Learn more about fractional shares .

What are the returns that Pasithea Therapeutics Corp has given to Indian investors in the last 5 years?

Pasithea Therapeutics Corp stock has given -99.16% share price returns and 29.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?